首页> 外文OA文献 >PD6-1-7: A phase II study of UCN-01 in combination with topotecan in patients (pts) with chemosensitive relapsed small cell lung cancer (SCLC): a study of the Princess Margaret Hospital phase II consortium (PMH-C).

【2h】

PD6-1-7: A phase II study of UCN-01 in combination with topotecan in patients (pts) with chemosensitive relapsed small cell lung cancer (SCLC): a study of the Princess Margaret Hospital phase II consortium (PMH-C).

机译：PD6-1-7：UCN-01联合拓扑替康治疗化学敏感性复发小细胞肺癌（SCLC）患者的II期研究：玛格丽特公主医院II期联合体（PMH-C）的研究。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Leighl Natasha; Laurie Scott; Gauthier Isabelle; Ellis Peter; Duguay Yannick; Pond Gregory; Bhagwat Manasi; Dancey Janet; Moore Malcolm; Goss Glenwood;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study. [J] . Hotte SJ, Oza A, Winquist EW, Annals of oncology: official journal of the European Society for Medical Oncology . 2006,第2期

机译：UCN-01联合拓扑替康治疗晚期实体瘤患者的I期临床试验：玛格丽特公主医院II期联合体研究。
2. Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study [J] . S. J. Hotte, A. Oza, E. W. Winquist, Annals of Oncology . 2006,第2期

机译：UCN-01联合拓扑替康治疗晚期实体癌的I期临床试验：玛格丽特公主医院II联合体研究
3. Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study. [J] . Siu LL, Soulieres D, Chen EX, Journal of Clinical Oncology . 2007,第16期

机译：厄洛替尼和顺铂在复发或转移性头颈部鳞状细胞癌患者中进行的I / II期临床试验：玛格丽特公主医院II期联合体和加拿大国家癌症研究所临床试验小组研究。
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. A Phase II Study of Pazopanib in Patients with Recurrent or Metastatic Invasive Breast Carcinoma: A Trial of the Princess Margaret Hospital Phase II Consortium [O] . Sara K. Taylor, Stephen Chia, Susan Dent, 2010

机译：帕唑帕尼在复发或转移性浸润性乳腺癌患者中的II期研究：玛格丽特公主医院II期联合体的试验
7. A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401 [O] . Nogami, Naoyuki, Hotta, Katsuyuki, Kuyama, Shoichi, 2011

机译：氨柔比星和拓扑替康联合疗法在复发或广泛疾病小细胞肺癌患者中的II期研究：冈山肺癌研究小组试验0401

PD6-1-7: A phase II study of UCN-01 in combination with topotecan in patients (pts) with chemosensitive relapsed small cell lung cancer (SCLC): a study of the Princess Margaret Hospital phase II consortium (PMH-C).

著录项

相似文献

相关主题

期刊订阅